KayoThera
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $10M
Investors
- 5
About KayoThera
, operates as a biotechnology company that develops immuno- and targeted therapies to cure cancer. In March 2022, KayoThera, Inc. As of 2023, Thong Q. Le acts as the President and CEO of the company. KayoThera offers therapies to treat late-stage and metastatic cancers, including breast, lung, pancreatic, colorectal, brain, and kidney cancers.
Who invested in KayoThera
5 investors across 2 rounds
See all investors in KayoThera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KayoThera
Who invested in KayoThera?
KayoThera has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KayoThera raised?
KayoThera has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did KayoThera last raise money?
KayoThera's most recent round on record is a Series A, in Jul 2023.
What does KayoThera do?
, operates as a biotechnology company that develops immuno- and targeted therapies to cure cancer.
Where is KayoThera headquartered?
KayoThera is headquartered in Seattle, US.
Which VCs invest in companies like KayoThera?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at KayoThera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like KayoThera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.